DXCM
$137.87
Revenue | $1034.5Mn |
Net Profits | $256.3Mn |
Net Profit Margins | 24.78% |
Dexcom, Inc.’s revenue jumped 26.9% since last year same period to $1034.5Mn in the Q4 2023. On a quarterly growth basis, Dexcom, Inc. has generated 6.1% jump in its revenue since last 3-months.
Dexcom, Inc.’s net profit jumped 179.19% since last year same period to $256.3Mn in the Q4 2023. On a quarterly growth basis, Dexcom, Inc. has generated 112.34% jump in its net profits since last 3-months.
Dexcom, Inc.’s net profit margin jumped 120.01% since last year same period to 24.78% in the Q4 2023. On a quarterly growth basis, Dexcom, Inc. has generated 100.13% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.27 |
EPS Estimate Current Year | 0.27 |
Dexcom, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.27 - a -37.21% fall from last quarter’s estimates.
Dexcom, Inc.’s earning per share (EPS) estimates for the current year stand at 0.27.
Earning Per Share (EPS) | 0.5 |
Dexcom, Inc.’s earning per share (EPS) jumped 47.06% since last year same period to 0.5 in the Q4 2023. This indicates that the Dexcom, Inc. has generated 47.06% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-04-27 | 0.15 | 0.17 | 13.33% |
2023-10-26 | 0.34 | 0.5 | 47.06% |
2023-07-27 | 0.23 | 0.34 | 47.83% |
2024-02-08 | 0.43 | 0.5 | 16.28% |